Extracellular matrix remodeling and cardiac fibrosis

被引:460
作者
Li, Li
Zhao, Qian
Kong, Wei [1 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Physiol & Pathophysiol, 38th Xueyuan Rd, Beijing 100191, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Extracellular matrix; Matrix remodeling; Cardiac fibrosis; Myofibroblasts; Matricellular proteins; CARDIOVASCULAR MAGNETIC-RESONANCE; FIBRILLAR COLLAGEN CONTENT; DIASTOLIC FUNCTION ROLE; MYOCARDIAL FIBROSIS; HEART-FAILURE; PRESSURE-OVERLOAD; TENASCIN-C; PERIOSTIN EXPRESSION; ISCHEMIC CARDIOMYOPATHY; TGF-BETA;
D O I
10.1016/j.matbio.2018.01.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Cardiac fibrosis, characterized by excessive deposition of extracellular matrix (ECM) proteins in the myocardium, distorts the architecture of the myocardium, facilitates the progression of arrhythmia and cardiac dysfunction, and influences the clinical course and outcome in patients with heart failure. This review describes the composition and homeostasis in normal cardiac interstitial matrix and introduces cellular and molecular mechanisms involved in cardiac fibrosis. We also characterize the ECM alteration in the fibrotic response under diverse cardiac pathological conditions and depict the role of matricellular proteins in the pathogenesis of cardiac fibrosis. Moreover, the diagnosis of cardiac fibrosis based on imaging and biomarker detection and the therapeutic strategies are addressed. Understanding the comprehensive molecules and pathways involved in ECM homeostasis and remodeling may provide important novel potential targets for preventing and treating cardiac fibrosis. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:490 / 506
页数:17
相关论文
共 181 条
[81]
Lijnen P. J., 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P51
[82]
The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients [J].
Lin, Yen-Hung ;
Lin, Lian-Yu ;
Wu, Yen-Wen ;
Chien, Kuo-Liong ;
Lee, Chi-Ming ;
Hsu, Ron-Bin ;
Chao, Chia-Lun ;
Wang, Shoei-Shen ;
Hsein, Yenh-Chen ;
Liao, Lin-Chu ;
Ho, Yi-Lwun ;
Chen, Ming-Fong .
CLINICA CHIMICA ACTA, 2009, 409 (1-2) :96-99
[83]
Temporal and Spatial Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Following Myocardial Infarction [J].
Lindsey, Merry L. ;
Zamilpa, Rogelio .
CARDIOVASCULAR THERAPEUTICS, 2012, 30 (01) :31-41
[84]
Effect of a cleavage-resistant collagen mutation on left ventricular remodeling [J].
Lindsey, ML ;
Yoshioka, J ;
MacGillivray, C ;
Muangman, S ;
Gannon, J ;
Verghese, A ;
Aikawa, M ;
Libby, P ;
Krane, SM ;
Lee, RT .
CIRCULATION RESEARCH, 2003, 93 (03) :238-245
[85]
Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure [J].
Liu, Tong ;
Song, Deli ;
Dong, Jianzeng ;
Zhu, Pinghui ;
Liu, Jie ;
Liu, Wei ;
Ma, Xiaohai ;
Zhao, Lei ;
Ling, Shukuan .
FRONTIERS IN PHYSIOLOGY, 2017, 8
[86]
Heart Disease and Stroke Statistics-2010 Update A Report From the American Heart Association [J].
Lloyd-Jones, Donald ;
Adams, Robert J. ;
Brown, Todd M. ;
Carnethon, Mercedes ;
Dai, Shifan ;
De Simone, Giovanni ;
Ferguson, T. Bruce ;
Ford, Earl ;
Furie, Karen ;
Gillespie, Cathleen ;
Go, Alan ;
Greenlund, Kurt ;
Haase, Nancy ;
Hailpern, Susan ;
Ho, P. Michael ;
Howard, Virginia ;
Kissela, Brett ;
Kittner, Steven ;
Lackland, Daniel ;
Lisabeth, Lynda ;
Marelli, Ariane ;
McDermott, Mary M. ;
Meigs, James ;
Mozaffarian, Dariush ;
Mussolino, Michael ;
Nichol, Graham ;
Roger, Veronique L. ;
Rosamond, Wayne ;
Sacco, Ralph ;
Sorlie, Paul ;
Stafford, Randall ;
Thom, Thomas ;
Wasserthiel-Smoller, Sylvia ;
Wong, Nathan D. ;
Wylie-Rosett, Judith .
CIRCULATION, 2010, 121 (07) :E46-E215
[87]
Myocardial collagen turnover in hypertrophic cardiomyopathy [J].
Lombardi, R ;
Betocchi, S ;
Losi, MA ;
Tocchetti, CG ;
Aversa, M ;
Miranda, M ;
D'Alessandro, G ;
Cacace, A ;
Ciampi, Q ;
Chiariello, M .
CIRCULATION, 2003, 108 (12) :1455-1460
[88]
Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure [J].
Lopez, Begona ;
Gonzalez, Arantxa ;
Beaumont, Javier ;
Querejeta, Ramon ;
Larman, Mariano ;
Diez, Javier .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (09) :859-867
[89]
Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial [J].
Lopez-Andres, Natalia ;
Rossignol, Patrick ;
Iraqi, Wafae ;
Fay, Renaud ;
Nuee, Josette ;
Ghio, Stefano ;
Cleland, John G. F. ;
Zannad, Faiez ;
Lacolley, Patrick .
EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (01) :74-81
[90]
Diagnostic approaches for diabetic cardiomyopathy [J].
Lorenzo-Almoros, A. ;
Tunon, J. ;
Orejas, M. ;
Cortes, M. ;
Egido, J. ;
Lorenzo, O. .
CARDIOVASCULAR DIABETOLOGY, 2017, 16